Chemoinformaics analysis of (4Z)-1-METHYL-4-(6-METHYLHEPT-5-EN-2-YLIDENE)CYCLOHEXENE
| Molecular Weight | 204.357 | nRot | 3 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 40 |
| Exact Molecular Weight | 204.188 | nRing | 1 |
| Solubility: LogS | -3.923 | nHRing | 0 |
| Solubility: LogP | 3.928 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 41.053 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.326 |
| Synth | 5.608 |
| Natural Product Likeliness | 0.782 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 1 |
| Pgp-sub | 0.022 |
| HIA | 0.317 |
| CACO-2 | -5.616 |
| MDCK | 0.00000642 |
| BBB | 0.454 |
| PPB | 0.923782 |
| VDSS | 1.562 |
| FU | 0.0309887 |
| CYP1A2-inh | 0.038 |
| CYP1A2-sub | 0.14 |
| CYP2c19-inh | 0.828 |
| CYP2c19-sub | 0.893 |
| CYP2c9-inh | 0.734 |
| CYP2c9-sub | 0.607 |
| CYP2d6-inh | 0.958 |
| CYP2d6-sub | 0.893 |
| CYP3a4-inh | 0.966 |
| CYP3a4-sub | 0.88 |
| CL | 8.311 |
| T12 | 0.471 |
| hERG | 0.57 |
| Ames | 0.714 |
| ROA | 0.869 |
| SkinSen | 0.04 |
| Carcinogencity | 0.82 |
| EI | 0.005 |
| Respiratory | 0.394 |
| NR-Aromatase | 0.089 |
| Antiviral | Yes |
| Prediction | 0.80714 |